These time-tested growth stocks won't bat an eye if stock market volatility returns.
News & Analysis: Alexion Pharmaceuticals
These disruptive businesses look virtually unstoppable.
Despite the big gains in recent months, not every stock is overpriced.
Value stocks have handily outperformed growth stocks over the very long run.
These time-tested businesses have a history of delivering huge returns for long-term investors.
Stocks in the Nasdaq were generally higher, but these two stood out.
These healthcare stocks are already dominant, and it should remain that way for a long time to come.
ALXN earnings call for the period ending March 31, 2020.
Alexion Pharmaceuticals made a move to acquire Portola Pharmaceuticals.
Which stock wins in a battle between these two biotechs?